Mediclinic acquires two medical clinics in Dubai
Private international healthcare provider, Mediclinic, has announced that it is set to acquire outpatient facility Dubai based City Centre Clinics Deira and Me’aisem from Majid Al Futtaim, a leading shopping mall, retail and leisure pioneer across the Middle East and North Africa.
Mediclinic Middle East currently operates six hospitals and 23 clinics with more than 700 inpatient beds in the United Arab Emirates.
Established in 2013, City Centre Clinics Deira encompasses two day-care surgery theatres and 18 medical disciplines, whilst City Centre Clinic Me’aisem houses a smaller community clinic focused on six core disciplines.
Both clinics serve strategic geographic locations which could refer higher acuity inpatient cases to existing Mediclinic hospitals and the forthcoming Mediclinic Parkview Hospital. Significant potential also exists to attract additional doctors and over time to grow patient volumes and revenues.
The clinics can also be efficiently integrated into Mediclinic’s clinical governance framework, support systems and brand.
City Centre Clinic Deira was originally built to provide quality healthcare to shopping mall visitors as part of its integrated lifestyle offering. This agreement will give Mediclinic the opportunity to partner with Majid Al Futtaim in future locations, increasing Mediclinic’s brand recognition within high footfall retail environments, a strategy which has been successfully implemented with existing Mediclinic primary healthcare facilities in other malls.
“Following the success of existing mall clinics in Dubai, Mediclinic identified an opportunity with Majid Al Futtaim at City Centre Clinics Deira and Me’aisem to build additional presence in some of Dubai’s leading retail and entertainment hubs,” explained David Hadley, CEO of Mediclinic Middle East.
- New archetypes are transforming healthcare, new PwC report finds
- Ascension and Ramsay Health Care partner on a new supply chain venture
- GDPR and healthcare - how to ensure a clean bill of health
Fully committed to supporting medical professionals across the Middle East, Mediclinic has also recently signed a Memorandum of Understanding (MoU) with Fatima College of Health Sciences to facilitate academic collaboration and create learning and development opportunities for UAE Nationals.
The MoU will pave the way for students enrolled in Nursing, Health Emergency (paramedics), Pharmacy, Radiography and Physiotherapy to experience on-the-job training in various Mediclinic facilities across the UAE.
“Partnerships with educational institutions such as Fatima College of Health Sciences creates an avenue for UAE Nationals to hone their clinical skills through the provision of patient-centric learning experiences under the supervision and guidance of clinical professionals at various Mediclinic facilities,” said Dr. Tarek Fathey, Chief Operating Office of Mediclinic East.
Additionally, with the launch of new digital tools across the healthcare space, Mediclinic has also integrated AI-driven solution company Vectra’s Cognito software to fully support its aim to protect patient data from potential cyber-attacks.
"Cognito gives us consistent, real-time visibility to detect and respond to cyberattacks, no matter where they occur," commented Marais Coetzee, Group Security Architect at Mediclinic. "The visual quality of this instant feedback lets us respond faster and more decisively to stop advanced threats."
"The healthcare industry is one of the top targets of cyberattacks and lives are literally at stake," said Vectra CEO Hitesh Sheth. "With Cognito, healthcare organisations have visibility into attacker behaviours in cloud and data centre workloads and user and IoT devices, enabling them to stop attacks in progress and improve the efficiency of security operations."
Data de-identification - why it matters in healthcare
Large amounts of healthcare data is generated yet goes unused due to privacy concerns. To address this, data privacy firm TripleBlind has created Blind De-identification, a new approach that allows healthcare organisations to use patient data while eliminating the possibility of the user learning anything about the patient’s identity.
We asked Riddhiman Das, co-founder and CEO to tell us more about data de-identification.
Why is data de-identification important in healthcare?
Blind De-identification allows every attribute of any given dataset to be used, even at an individual level, while being compliant to privacy laws, rules, and regulations by default.
Governments around the world are adopting global data privacy and residency laws like GDPR, which prohibit citizens’ personally identifiable information data from leaving the borders of the country. While great for data protection, data residency laws result in global silos of inaccessible data. TripleBlind allows computations to be done on enterprise-wise global data, while enforcing data residency regulations.
In the US, HIPAA compliance has relied on what is called the Safe Harbor method, which requires removing 18 types of personal patient identifiers like names, email addresses, and medical record numbers. The Safe Harbor method can be too restrictive with the data or can leave too many indirect identifiers, which puts the patient data security at risk. Getting de-identification wrong could make an organisation liable for a costly mistake.
What does TripleBlind's solution do?
With TripleBlind, data is legally de-identified in real time with practically 0% probability of re-identification. Our solution allows analytics on data containing personally identifiable information and protected health information with zero possibility of re-identifying an individual from the dataset. This allows healthcare organisations to access more meaningful data, creating more accurate and less biased results.
For example, a healthcare drug researcher in a rural, predominantly white area, would only have patient data that would reflect their local population. With TripleBlind’s de-identification, they could more easily leverage third-party data from another healthcare facility in a more diverse region, creating a more complete data set that more accurately reflects the larger population. This has the possibility to create more accurate diagnoses and better drug results for more diverse populations.
How can healthcare organisations use this in practice?
TripleBlind is blind to all data and algorithms. That means we never take possession of customer data. We only route traffic between entities, enforce permissions, and provide audit trails. The enterprise’s data remains under their control. TripleBlind does not host, copy or control their data, algorithms or other information assets, ever.
We facilitate a connection to an encrypted version of their information assets. Our technology allows the algorithms and data to interact in an encrypted space that only exists for the duration of the operation. Organisations use their existing infrastructure, so it’s not hardware dependent.